119 related articles for article (PubMed ID: 38160571)
61. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
Mounier M; Bossard N; Remontet L; Belot A; Minicozzi P; De Angelis R; Capocaccia R; Iwaz J; Monnereau A; Troussard X; Sant M; Maynadié M; Giorgi R; ;
Lancet Haematol; 2015 Nov; 2(11):e481-91. PubMed ID: 26686258
[TBL] [Abstract][Full Text] [Related]
62. Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients.
Pehalova L; Krejci D; Halamkova J; Smardova L; Snajdrova L; Dusek L
Cancer Epidemiol; 2021 Jun; 72():101929. PubMed ID: 33819838
[TBL] [Abstract][Full Text] [Related]
63. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
Ohshima K; Suzumiya J; Kikuchi M
Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
[TBL] [Abstract][Full Text] [Related]
64. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
Idris M; Shah SH; Fareed J; Gul N
J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
[TBL] [Abstract][Full Text] [Related]
65. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
66. Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.
Horsboel TA; Nielsen CV; Nielsen B; Andersen NT; De Thurah A
Acta Oncol; 2015 May; 54(5):743-9. PubMed ID: 25752974
[TBL] [Abstract][Full Text] [Related]
67. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
Pulte D; Jansen L; Brenner H
Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
[TBL] [Abstract][Full Text] [Related]
68. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
69. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
70. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
Sant M; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Visser O; Marcos-Gragera R; Maynadié M; Simonetti A; Lutz JM; Berrino F;
Blood; 2010 Nov; 116(19):3724-34. PubMed ID: 20664057
[TBL] [Abstract][Full Text] [Related]
71. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
73. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
74. Variation in survival of adult patients with haematological malignancies in Europe since 1978. EUROCARE Working Group.
Carli PM; Coebergh JW; Verdecchia A
Eur J Cancer; 1998 Dec; 34(14 Spec No):2253-63. PubMed ID: 10070296
[TBL] [Abstract][Full Text] [Related]
75. Epidemiological Trends of Haematological Malignancies in Belgium 2004-2018: Older Patients Show the Greatest Improvement in Survival.
Henau K; Tambuyzer T; Van Gool B; Van Eycken L; Poirel HA
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686664
[TBL] [Abstract][Full Text] [Related]
76. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
77. The incidence of hematological neoplasms morbidity on radiation-contaminated territories in Cherkasy region.
Paramonov VV
Probl Radiac Med Radiobiol; 2017 Dec; 22():428-449. PubMed ID: 29286525
[TBL] [Abstract][Full Text] [Related]
78. Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers-A qualitative study from the UK's Haematological Malignancy Research Network.
Howell DA; McCaughan D; Smith AG; Patmore R; Roman E
PLoS One; 2022; 17(2):e0263672. PubMed ID: 35143569
[TBL] [Abstract][Full Text] [Related]
79. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
80. Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.
Kane E; Painter D; Smith A; Lamb M; Oliver SE; Patmore R; Roman E
Int J Cancer; 2020 Aug; 147(3):702-708. PubMed ID: 31675431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
